DD GROUP Co.,Ltd. Logo

DD GROUP Co.,Ltd.

Operates a diverse portfolio of food service, amusement, and hotel brands.

3073 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区芝4−1−23 三田NNビル18F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DD GROUP Co., Ltd. is a multifaceted enterprise principally engaged in the food service and amusement sectors. The company's core activities involve the planning, management, and operation of a diverse portfolio of businesses, including themed restaurants, pubs, cafes, and amusement facilities. The group has also expanded its operations to include the hotel business. Emphasizing a "brand company" philosophy, DD GROUP is dedicated to the continuous creation and development of innovative brands. Through its various group companies, it manages over 100 distinct brands across an extensive network of locations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 09:00
M&A Activity
訂正意見表明報告書
Japanese 229.2 KB
2025-07-15 07:18
M&A Activity
意見表明報告書
Japanese 425.5 KB
2025-05-30 09:01
Governance Information
内部統制報告書-第29期(2024/03/01-2025/02/28)
Japanese 24.4 KB
2025-05-30 09:00
Registration Form
有価証券報告書-第29期(2024/03/01-2025/02/28)
Japanese 1.8 MB
2025-05-30 09:00
Registration Form
確認書
Japanese 9.0 KB
2025-05-30 04:00
Regulatory News Service
臨時報告書
Japanese 24.8 KB
2025-04-14 09:15
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-02-28 03:00
Post-Annual General Meeting Information
臨時報告書
Japanese 22.3 KB
2024-10-15 09:00
Interim Report
半期報告書-第29期(2024/03/01-2025/02/28)
Japanese 279.9 KB
2024-10-15 09:00
Interim Report
確認書
Japanese 9.0 KB
2024-07-12 09:00
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-07-12 09:00
Quarterly Report
四半期報告書-第29期第1四半期(2024/03/01-2024/05/31)
Japanese 223.4 KB
2024-07-02 09:12
Major Shareholding Notification
変更報告書
Japanese 40.0 KB
2024-05-30 09:01
Governance Information
内部統制報告書-第28期(2023/03/01-2024/05/29)
Japanese 23.8 KB
2024-05-30 09:00
Registration Form
有価証券報告書-第28期(2023/03/01-2024/02/29)
Japanese 1.8 MB

Automate Your Workflow. Get a real-time feed of all DD GROUP Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DD GROUP Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.